한국임상수의학회지 (Journal of Veterinary Clinics)

  • 제35권2호
  • /
  • Pages.50-52
  • /
  • 2018
  • /
  • 1598-298X(pISSN)
  • /
  • 2384-0749(eISSN)
한국임상수의학회 (The Korean Society of Veterinary Clinics)
권호 표지
DOI QR코드

DOI QR Code

Botulinum Toxin Injection before Surgical Intervention in a Dog with Cricopharyngeal Achalasia

  • Bae, Seul-gi (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Kyungpook National University) ;
  • Yun, Sungho (Department of Veterinary Surgery, College of Veterinary Medicine, Kyungpook National University)
  • 투고 : 2018.02.07
  • 심사 : 2018.04.13
  • 발행 : 2018.04.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

A 6-month-old castrated male poodle presented with a cough, dysphagia, and regurgitation. Cricopharyngeal achalasia (CPA) was diagnosed by clinical history and a fluoroscopic examination. The animal received a botulinum toxin (BTX) injection but symptoms had not resolved by three days after injection. Thus, a cricopharyngeal and thyropharyngeal muscle myotomy was performed and immediately the clinical signs resolved. This report describes successful correction of CPA with myotomy after failure of BTX injection in a dog.

키워드

참고문헌

  1. Blitzer A, Brin MF. Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia. Otolaryngol Head Neck Surg 1997; 116: 328-330. https://doi.org/10.1016/S0194-5998(97)70267-5
  2. Bonington A, Mahon M, Whitmore I. A histological and histochemical study of the cricopharyngeus muscle in man. J Anat 1988; 156: 27-37.
  3. Brin MF, Lew MF, Adler CH, Comella CL, Factor SA, Jankovic J, O'Brien C, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 1999; 53: 1431-1438. https://doi.org/10.1212/WNL.53.7.1431
  4. Fossum TW, Radlinsky MG. Surgery of digestive system. In: Small animal surgery, 4th ed. St. Louis; Elsevier health sciences. 2013: 453-456.
  5. Elliott RC. An anatomical and clinical review of cricopharyngeal achalasia in the dog. J S Afr Vet Assoc 2010; 81: 75-79.
  6. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991; 324: 1186-1194. https://doi.org/10.1056/NEJM199104253241707
  7. Kelly EA, Koszewski IJ, Jaradeh SS, Merati AL, Blumin JH, Bock JM. Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction. Ann Otol Rhinol Laryngol 2013; 122: 100-108. https://doi.org/10.1177/000348941312200205
  8. Kocdor P, Siegel ER, Tulunay-Ugur OE. Cricopharyngeal dysfunction: A systematic review comparing outcomes of dilatation, botulinum toxin injection, and myotomy. Laryngoscope 2016; 126: 135-141. https://doi.org/10.1002/lary.25447
  9. Langlois DK, Stanley BJ, Ballegeer EA. Successful treatment of cricopharyngeal dysphagia with bilateral myectomy in a dog. Can Vet J 2014; 55: 1167-1172.
  10. Laurikainen E, Aitasalo K, Halonen P, Falck B, Kalimo H. Muscle pathology in idiopathic cricopharyngeal dysphagia. Eur Arch Otorhinolaryngol 1992; 249: 216-223.
  11. Ludlow CL, Hallett M, Rhew K, Cole R, Shimizu T, Bagley J, Schulz G, Bagley JA, Schulz GM, Yin SG, Koda J. Therapeutic use of type F botulinum toxin. N Engl J Med 1992; 326: 349-350. https://doi.org/10.1056/NEJM199201303260516
  12. Mezaki T, Kaji R, Kohara N, Fujii H, Katayama M, Shimizu T, Kimura J, Brin MF. Comparison of Therapeutic Efficacies of Type A and F Botulinum Toxins for Blepharospasm A double-blind, controlled study. Neurology 1995; 45: 506-508. https://doi.org/10.1212/WNL.45.3.506
  13. Murry T, Wasserman T, Carrau RL, Castillo B. Injection of botulinum toxin A for the treatment of dysfunction of the upper esophageal sphincter. Am J Otolaryngol 2005; 26: 157-162. https://doi.org/10.1016/j.amjoto.2004.11.010
  14. Niles JD, Williams JM, Sullivan M, Crowsley FE. Resolution of dysphagia following cricopharyngeal myectomy in six young dogs. J Small Anim Pract 2001; 42: 32-35. https://doi.org/10.1111/j.1748-5827.2001.tb01982.x
  15. Papazoglou LG, Mann F, Warnock JJ, Song KJE. Cricopharyngeal dysphagia in dogs: The lateral approach for surgical management. Com Cont Educ Pract Vet 2006; 28: 696-704.
  16. Pollard RE, Marks SL, Davidson A, Hornof WJ. Quantitative videofluoroscopic evaluation of pharyngeal function in the dog. Vet Radiol Ultrasound 2000; 41: 409-412. https://doi.org/10.1111/j.1740-8261.2000.tb01862.x
  17. Sankhla C, Jankovic J, Duane D. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections. Mov Disord 1998; 13: 150-154. https://doi.org/10.1002/mds.870130128
  18. Schneider I, Thumfart WF, Pototschnig C, Eckel HE. Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method. Ann Otol Rhinol Laryngol 1994; 103: 31-35.
  19. Skinner MA, Shorter NA. Primary neonatal cricopharyngeal achalasia: a case report and review of the literature. J Pediatr Surg 1992; 27: 1509-1511. https://doi.org/10.1016/0022-3468(92)90487-R
  20. Warnock JJ, Marks SL, Pollard R, Kyles AE, Davidson A. Surgical management of cricopharyngeal dysphagia in dogs: 14 cases (1989-2001). J Am Vet Med Assoc 2003; 223: 1462-1468. https://doi.org/10.2460/javma.2003.223.1462
  21. Watrous B, Suter P. Normal swallowing in the dog: a cineradiographic study. Vet Radiol Ultrasound 1979; 20: 99-109. https://doi.org/10.1111/j.1740-8261.1979.tb01187.x
  22. Watrous BJ. Clinical presentation and diagnosis of dysphagia. Vet Clin North Am Small Anim Pract 1983; 13: 437-459. https://doi.org/10.1016/S0195-5616(83)50052-1
  23. Zaninotto G, Marchese Ragona RM, Briani C, Costantini M, Rizzetto C, Portale G, Zanetti L, Masiero S, Costantino M, Nicoletti L, Polidoro A, Feltrin G, Angelini C, ancona E, Guidolin D, Parenti AR. The role of botulinum toxin injection and upper esophageal sphincter myotomy in treating oropharyngeal dysphagia. J Gastrointest Surg 2004; 8: 997-1006. https://doi.org/10.1016/j.gassur.2004.09.037